U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07148752) titled 'Evaluation of Resveratrol and Its Loaded Nanoparticles on Acanthamoeba' on Aug. 11.
Brief Summary: Acanthamoeba is a free-living amoeba responsible for severe human infections. There are at least twenty-two different genotypes of Acanthamoeba (T1-T22). T4 is the most common virulent genotype, mainly Acanthamoeba castellani and Acanthamoeba polyphaga.
Proper treatment still represents a challenge for healthcare professionals.So, we need novel therapeutic strategies, including newer drugs and/or drug delivery systems that can overcome the developing drug resistance as well as have minimal toxicity to human cells.
There is a new appr...